ticlopidine has been researched along with Cancer of Ovary in 3 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of the present case report was to describe a novel pharmacokinetic drug–drug interaction between the antiplatelet agent clopidogrel and the antineoplastic agent paclitaxel." | 1.43 | Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60-year-old Caucasian woman with ovarian carcinoma. ( Backman, J; Bergmann, TK; Brosen, K; Filppula, AM; Launiainen, T; Nielsen, F, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alosh, M | 1 |
Huque, MF | 1 |
Koch, GG | 1 |
Bergmann, TK | 1 |
Filppula, AM | 1 |
Launiainen, T | 1 |
Nielsen, F | 1 |
Backman, J | 1 |
Brosen, K | 1 |
Essandoh, MK | 1 |
Dalia, AA | 1 |
George, BS | 1 |
Flores, AS | 1 |
Otey, AJ | 1 |
Kirtane, AJ | 1 |
Broderick, TM | 1 |
Rao, SV | 1 |
3 other studies available for ticlopidine and Cancer of Ovary
Article | Year |
---|---|
Statistical Perspectives on Subgroup Analysis: Testing for Heterogeneity and Evaluating Error Rate for the Complementary Subgroup.
Topics: Algorithms; Antibiotics, Antineoplastic; Antineoplastic Agents; Aspirin; Clinical Trials as Topic; C | 2015 |
Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60-year-old Caucasian woman with ovarian carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cytochrome P-450 CYP2 | 2016 |
CASE 11-2016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?
Topics: Analgesics, Opioid; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopid | 2016 |